Echo Therapeutics, Inc. 4/A
4/A · Echo Therapeutics, Inc. · Filed Jul 9, 2013
Insider Transaction Report
Form 4/AAmended
SMITH JAMES FRANCIS
Director
Transactions
- Award
Nonqualified Stock Option (right to buy)
2013-07-01+1,500→ 3,000 totalExercise: $2.49From: 2014-07-01Exp: 2023-07-01→ Common Stock (1,500 underlying) - Award
Common Stock
2013-07-01+400→ 8,000 total
Footnotes (3)
- [F1]The shares vest on July 1, 2014, provided, however that all unvested Restricted Shares shall immediately vest upon the sale of or substantially all of the assets of the Company of all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As used herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities.
- [F2]This amendment to Form 4 is to properly reflect beneficial ownership following a 1 for 10 reverse stock split on June 7, 2013. The transactions reported on the Form 4 dated July 1, 2013 were accurate.
- [F3]The Options vest on July 1, 2014; provided, however, that all unvested Options shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or sustainably all of the outstanding capital stock of the Company in exchange for Liquid Proceeds.